Citations Database

Submit Your Publication

GenScript services and products have been used extensively by scientists worldwide to improve their research efficiency. Here, we have collected a representation of citations for your reference.

Date from
Page: 1/1 Results per page
BRAF Modulates Lipid Use and Accumulation
Authors: Jacqueline A Turner, Emily L Paton, Robert Van Gulick, Davide Stefanoni, Francesca Cendali, Julie Reisz, Richard P Tobin, Martin McCarter, Angelo D'Alessandro, Raul M Torres, William A Robinson, Kasey L Couts, Isabel R Schlaepfer
Journal: Cancers (Basel)
PubMed ID: 35565240
Doi: 10.3390/cancers14092110
Products & Services: Mutagenesis Services   
Programmable human histone phosphorylation and gene activation using a CRISPR/Cas9-based chromatin kinase
Authors: Jing Li, Barun Mahata, Mario Escobar, Jacob Goell, Kaiyuan Wang, Pranav Khemka, Isaac B Hilton
Journal: Nat Commun
PubMed ID: 33563994
Doi: 10.1038/s41467-021-21188-2
Products & Services: Oligo pool   
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Authors: Klotz-Noack K, Klinger B, Rivera M, Bublitz N, Uhlitz F, Riemer P, Lüthen M, Sell T, Kasack K, Gastl B, Ispasanie SSS, Simon T, Janssen N, Schwab M, Zuber J, Horst D, Blüthgen N, Schäfer R, Morkel M, Sers C
Journal: Cell Reports
PubMed ID: 32966782
Doi: 10.1016/j.celrep.2020.108184
Products & Services: Oligo pool   
[Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance]
Authors: L P Liu, J Y Hao, H Pan, C Wang, P Yue
Journal: Zhonghua Bing Li Xue Za Zhi
PubMed ID: 32187898
Doi: 10.3760/cma.j.issn.0529-5807.2020.03.007
Products & Services: PCR Cloning and Subcloning   
Mechanisms of acquired resistance to afatinib clarified with liquid biopsy.
Authors: Nakamura T, Nakashima C, Komiya K, Kitera K, Hirai M, Kimura S, Aragane N.
Journal: PLoS ONE
PubMed ID: 30550608
Doi: 10.1371/journal.pone.0209384
Products & Services: Plasmid DNA Preparation   
Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma.
Authors: CintoloJessica A,DattaJashodeep,XuShuwen,GuptaMeera,SomasundaramRajasekharan,CzernieckiBri
Journal: Melanoma Res.
PubMed ID: 26451873
Doi: 10.1097/CMR.0000000000000203
Products & Services: Peptide Synthesis   
The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.
Authors: Li JX, Feng JM, Wang Y, Li XH, Chen XX, Su Y, Shen YY, Chen Y, Xiong, Yang CH, Ding J, Miao ZH.
Journal: Cell Death Dis. 5:e1278
PubMed ID: 24901049
Products & Services: Peptide Synthesis   
Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma.
Authors: Bid HK, Kibler A, Phelps D, Manap S, Xiao L, Lin J, Capper D, Oswald D, Geier B, Dewire M, Smith PD, Kurmasheva RT, Mo X, Fernandez S, Houghton PJ.
Journal: Clin Cancer Res.
PubMed ID: 24132923
Products & Services: Peptide Synthesis   
Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E.
Authors: Esteve-Puig R, Canals F, ColomÉ N, Merlino G, Recio JA.
Journal: PLoS One. 4(3):e4711
PubMed ID: 19274086
Products & Services: Peptide Synthesis   
< 1 > Total Pages 1

Do you like the current new website?